This study presents the findings of a national survey of physicians about their knowledge of biosimilar biological products as well as the impact of biological product naming conventions on prescriber choice.
Related Products
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Allison Kolbe, (202) 839-1508, Allison.kolbe@hhs.gov. Content will be updated pending the outcome of the Section 508 review.